Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Kiniksa Pharmaceuticals International (KNSA) Gross Profit (2021 - 2025)

Historic Gross Profit for Kiniksa Pharmaceuticals International (KNSA) over the last 5 years, with Q3 2025 value amounting to $160.6 million.

  • Kiniksa Pharmaceuticals International's Gross Profit rose 7436.4% to $160.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $523.3 million, marking a year-over-year increase of 5787.3%. This contributed to the annual value of $362.3 million for FY2024, which is 5297.7% up from last year.
  • Kiniksa Pharmaceuticals International's Gross Profit amounted to $160.6 million in Q3 2025, which was up 7436.4% from $138.2 million recorded in Q2 2025.
  • In the past 5 years, Kiniksa Pharmaceuticals International's Gross Profit registered a high of $160.6 million during Q3 2025, and its lowest value of -$155.0 million during Q4 2022.
  • In the last 5 years, Kiniksa Pharmaceuticals International's Gross Profit had a median value of $66.5 million in 2023 and averaged $57.8 million.
  • Examining YoY changes over the last 5 years, Kiniksa Pharmaceuticals International's Gross Profit showed a top increase of 88840.05% in 2022 and a maximum decrease of 114184.7% in 2022.
  • Over the past 5 years, Kiniksa Pharmaceuticals International's Gross Profit (Quarter) stood at $14.9 million in 2021, then crashed by 1141.85% to -$155.0 million in 2022, then soared by 147.62% to $73.8 million in 2023, then skyrocketed by 41.77% to $104.6 million in 2024, then surged by 53.48% to $160.6 million in 2025.
  • Its Gross Profit was $160.6 million in Q3 2025, compared to $138.2 million in Q2 2025 and $119.9 million in Q1 2025.